October 6, 2021 — Boston Scientific Corp. announced it entered into a definitive agreement to acquire Baylis Medical Company Inc. for an upfront payment of $1.75 billion, subject to closing ...
Left Atrial Appendage (LAA) Occluders
This channel includes news and new technology innovations about Left Atrial Appendage (LAA) Occluders. These close off the LAA in patients with atrial fibrillation to prevent the formation of stroke-causing clots in atrial fibrillation (AFib or AF) patients. LAA occlusion is often indicated for patients who do not tolerate anticoagulation therpy or have bleeding risks associated with use of that therapy.
-
-
October 6, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of September 2021. This is based on the website’s ...
-
September 27, 2021 — Compared with men undergoing left atrial appendage occlusion (LAAO), women have a significantly higher risk of in-hospital adverse events, according to a recently published review ...
-
August 31, 2021 — Late-breaking data from a head-to-head clinical trial of the Amulet Left Atrial Appendage (LAA) Occluder FDA IDE trial showed the Amulet was superior for the primary endpoint of LAA ...
October 6, 2021 — Boston Scientific Corp. announced it entered into a definitive agreement to acquire Baylis Medical ...
October 06, 2021
Feature | BY Dave Fornell, DAIC Editor
October 6, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...
October 06, 2021
September 27, 2021 — Compared with men undergoing left atrial appendage occlusion (LAAO), women have a significantly ...
September 27, 2021
August 31, 2021 — Late-breaking data from a head-to-head clinical trial of the Amulet Left Atrial Appendage (LAA) ...
August 31, 2021
August 16, 2021 — The U.S. Food and Drug Administration (FDA) approved Abbott's Amplatzer Amulet Left Atrial Appendage ...
August 16, 2021
July 13, 2021 — East End Medical announced it received U.S. Food and Drug Administration (FDA) clearance for the company ...
July 14, 2021
June 28, 2021 — CentraCare, one of the largest health systems in Minnesota, successfully completed the first structural ...
June 28, 2021
May 15, 2021 - Transcatheter left atrial appendage occlusion (LAAO) with a Boston Scientific Watchman device was ...
May 16, 2021
May 15, 2021 — Patients with an elevated risk of stroke due to heart rhythm problems, or atrial fibrillation (AFib) ...
May 15, 2021
As a medical technology journalist, a little more than a decade ago I found myself sitting in those late afternoon ...
April 21, 2021
Feature | Hemostasis Management | Dave Fornell, Editor
While many cardiac and vascular procedures have largely moved to minimally invasive techniques, the size of these ...
March 09, 2021
The latest cardiology practice-changing scientific breakthrough, late-breaking study presentations have been announced ...
May 18, 2021
Oct. 29, 2020 — Boston Scientific initiated the CHAMPION-AF clinical trial to evaluate the safety and efficacy of the ...
October 29, 2020
October 16, 2020 — Positive clinical data from first-in-human studies of the Conformal Medical left atrial appendage ...
October 16, 2020
Feature | Udi Nussinovitch M.D., Ph.D.
This is an overview of some of the biggest cardiology technology advances. These innovations are covered in more detail ...
October 09, 2020© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now